Publications by authors named "Stefano Angelini"

Claim this Profile
U
Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT).
Piero Galieni, Emanuela Troiani, Paola Picardi, Mario Angelini, Francesca Mestichelli, Stefano Angelini

Leuk Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Analysis of Volume, Length and Segmentation of Free Fibula Flap in Reconstruction of the Jaws: Investigation of Their Role on Flap Failure.
Mattia Di Bartolomeo, Irene Laura Lusetti, Massimo Pinelli, Sara Negrello, Arrigo Pellacani, Stefano Angelini

Reports (MDPI)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major.
Stella Santarone, Stefano Angelini, Annalisa Natale, Doriana Vaddinelli, Raffaele Spadano

Bone Marrow Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tongue cancer following hematopoietic cell transplantation for Fanconi anemia.
Mattia Di Bartolomeo, Alexandre Anesi, Arrigo Pellacani, Sara Negrello, Annalisa Natale, Stefano Angelini

Clin Oral Investig· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance.
Marco Borghesi, Lorenzo Bianchi, Umberto Barbaresi, Valerio Vagnoni, Beniamino Corcioni, Stefano Angelini

Minerva Urol Nephrol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary oral cancer following hematopoietic cell transplantation.
Stella Santarone, Annalisa Natale, Stefano Angelini, Gabriele Papalinetti, Doriana Vaddinelli

Bone Marrow Transplant· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
Piero Galieni, Fosco Travaglini, Davide Vagnoni, Miriana Ruggieri, Patrizia Caraffa, Mario Angelini, Stefano Angelini

Br J Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Lifestyles, Substance-Related Behaviors, and Sexual Habits Among Italian Young Adult Males: An Epidemiologic Study.
Luca Flesia, Francesca Cavalieri, Stefano Angelini, Gioia Bottesi, Marta Ghisi

Sex Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Array CGH analysis reveals deletion of chromosome 22q11 in CLL with normal karyotype and no fish alterations.
Francesca Mestichelli, Alessia Dalsass, Silvia Ferretti, Elisa Camaioni, Mario Angelini, Stefano Angelini

Br J Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.
Davide Vagnoni, Fosco Travaglini, Valerio Pezzoni, Miriana Ruggieri, Catia Bigazzi, Mario Angelini, Stefano Angelini

Br J Haematol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Alessia Dalsass, Francesca Mestichelli, Miriana Ruggieri, Paola Gaspari, Valerio Pezzoni, Mario Angelini, Stefano Angelini

Eur J Haematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.
Paolo Di Bartolomeo, Stella Santarone, Gottardo De Angelis, Alessandra Picardi, Laura Cudillo, Stefano Angelini

Blood· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis